Vundavalli V. Murty

10.5k total citations · 3 hit papers
109 papers, 7.2k citations indexed

About

Vundavalli V. Murty is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Vundavalli V. Murty has authored 109 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 30 papers in Oncology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Vundavalli V. Murty's work include Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (13 papers) and Epigenetics and DNA Methylation (13 papers). Vundavalli V. Murty is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (13 papers) and Epigenetics and DNA Methylation (13 papers). Vundavalli V. Murty collaborates with scholars based in United States, Germany and Colombia. Vundavalli V. Murty's co-authors include Gopeshwar Narayan, Mahesh Mansukhani, Subhadra V. Nandula, Riccardo Dalla‐Favera, Hugo Arias‐Pulido, Laura Pasqualucci, Achim Schneider, Govind Bhagat, Robert Benezra and Loren S. Michel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Vundavalli V. Murty

108 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

2011 644 citations Laura Pasqualucci, Davide Rossi et al. Nature profile →
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells

2001 610 citations Loren S. Michel, Vundavalli V. Murty et al. Nature profile →
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

2014 398 citations Aruna Kode, John S. Manavalan et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vundavalli V. Murty United States	40	4.4k	1.9k	1.3k	1.2k	939	109	7.2k
Susanne M. Gollin United States	48	4.4k 1.0×	2.0k 1.1×	1.6k 1.2×	580 0.5×	685 0.7×	141	7.2k
Bryan D. Young United Kingdom	61	5.2k 1.2×	1.6k 0.8×	1.6k 1.2×	1.3k 1.0×	900 1.0×	191	9.2k
Dennis K. Watson United States	41	3.6k 0.8×	1.3k 0.7×	1.0k 0.8×	742 0.6×	904 1.0×	106	5.8k
Pierre Dubus France	42	5.3k 1.2×	4.0k 2.1×	1.2k 0.9×	1.1k 0.9×	1.1k 1.1×	163	9.7k
Deborah J. Marsh Australia	43	4.2k 1.0×	1.8k 1.0×	1.3k 0.9×	929 0.8×	542 0.6×	130	7.4k
Adam B. Glick United States	47	4.6k 1.1×	1.6k 0.9×	893 0.7×	441 0.4×	787 0.8×	109	7.4k
Marikki Laiho Finland	42	6.8k 1.6×	2.8k 1.5×	1.7k 1.2×	574 0.5×	496 0.5×	116	9.2k
Martín E. Fernández-Zapico United States	47	5.0k 1.1×	3.0k 1.6×	1.5k 1.1×	449 0.4×	1.2k 1.2×	172	7.7k
Robert G. Ramsay Australia	50	3.6k 0.8×	2.1k 1.1×	939 0.7×	442 0.4×	934 1.0×	176	6.5k
Stefan K. Bohlander Germany	52	5.4k 1.2×	1.6k 0.9×	1.7k 1.3×	524 0.4×	934 1.0×	184	9.2k

Countries citing papers authored by Vundavalli V. Murty

Since Specialization

Citations

This map shows the geographic impact of Vundavalli V. Murty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vundavalli V. Murty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vundavalli V. Murty more than expected).

Fields of papers citing papers by Vundavalli V. Murty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vundavalli V. Murty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vundavalli V. Murty. The network helps show where Vundavalli V. Murty may publish in the future.

Co-authorship network of co-authors of Vundavalli V. Murty

This figure shows the co-authorship network connecting the top 25 collaborators of Vundavalli V. Murty. A scholar is included among the top collaborators of Vundavalli V. Murty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vundavalli V. Murty. Vundavalli V. Murty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scotto, Luigi, Beatrice Casadei, Eugene F. Douglass, et al.. (2020). Generation of pralatrexate resistant T‐cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers. Genes Chromosomes and Cancer. 59(11). 639–651. 3 indexed citations

Pagan, Carlos, Susan J. Hsiao, Mahesh Mansukhani, et al.. (2019). Targeting SLMAP-ALK—a novel gene fusion in lung adenocarcinoma. Molecular Case Studies. 5(3). a003939–a003939. 10 indexed citations

Mathur, Deepti, Ηλίας Στρατικόπουλος, Sait Öztürk, et al.. (2017). PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition. Cancer Discovery. 7(4). 380–390. 89 indexed citations

Lassman, Andrew B., Mahesh Mansukhani, Vundavalli V. Murty, et al.. (2017). ACTR-68. CONCORDANCE OF EGFR AND MGMT ANALYSES BETWEEN LOCAL AND CENTRAL LABORATORIES: IMPLICATIONS FOR CLINICAL TRIAL DESIGN AND PRECISION MEDICINE FOR DEPATUXIZUMAB-MAFODOTIN (ABT-414) IN GLIOBLASTOMA (GBM). Neuro-Oncology. 19(suppl_6). vi15–vi15. 8 indexed citations

Sulis, Maria Luisa, et al.. (2015). Childhood de novo CD5+ Diffuse Large B-cell Lymphoma: a Separate Entity?. PubMed. 45(5). 574–81. 1 indexed citations

Kode, Aruna, John S. Manavalan, Ioanna Mosialou, et al.. (2014). Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature. 506(7487). 240–244. 398 indexed citations breakdown →

Churg, Andrew, Alain Borczuk, Philip T. Cagle, et al.. (2014). Well-differentiated Papillary Mesothelioma With Invasive Foci. The American Journal of Surgical Pathology. 38(7). 990–998. 53 indexed citations

Zainabadi, Kayvan, Anuja Jain, Frank X. Donovan, et al.. (2014). One in four individuals of African-American ancestry harbors a 5.5 kb deletion at chromosome 11q13.1. Genomics. 103(4). 276–287. 5 indexed citations

Gowrishankar, Banumathy, Hikmat Al‐Ahmadie, Oscar Lin, et al.. (2014). Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization. British Journal of Urology. 114(6). 881–890. 5 indexed citations

10.

Lee, John C., Daniela Hoehn, Jordan M. Schecter, et al.. (2013). Lymphoid follicle colonization by Bcl-2bright+CD10+ B-cells (“follicular lymphoma in situ”) at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma. Human Pathology. 44(7). 1328–1340. 7 indexed citations

11.

Novak, Urban, Andrea Rinaldi, Ivo Kwee, et al.. (2009). The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood. 113(20). 4918–4921. 184 indexed citations

12.

Nandula, Subhadra V., et al.. (2008). Diffuse large B-cell lymphoma with TEL/ETV6 translocation. Human Pathology. 40(4). 588–593. 4 indexed citations

13.

Memeo, Lorenzo, Jeffrey S. Jhang, Adel Assaad, et al.. (2007). Immunohistochemical Analysis for Cytokeratin 7, KIT, and PAX2. American Journal of Clinical Pathology. 127(2). 225–229. 59 indexed citations

14.

Michel, Loren S., Elena Díaz‐Rodríguez, Gopeshwar Narayan, et al.. (2004). Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proceedings of the National Academy of Sciences. 101(13). 4459–4464. 158 indexed citations

15.

Koul, Sanjay, James M. McKiernan, Gopeshwar Narayan, et al.. (2004). Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.. Molecular Cancer. 3(1). 16–16. 116 indexed citations

16.

Lee, Francis Young‐In, et al.. (2002). Novel translocation (9;12)(q22;q24) in secondardy chondrosarcoma arising from hereditary multiple exostosis. Cancer Genetics and Cytogenetics. 132(1). 68–70. 7 indexed citations

17.

Mathew, Susan, Wei‐Yi Chen, Vundavalli V. Murty, Robert Benezra, & R. S. K. Chaganti. (1995). Chromosomal Assignment of HumanID1andID2Genes. Genomics. 30(2). 385–387. 19 indexed citations

18.

Murty, Vundavalli V., et al.. (1990). Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction. Genes Chromosomes and Cancer. 1(3). 228–232. 32 indexed citations

19.

Chaganti, R. S. K., I. Balazs, S.C. Jhanwar, et al.. (1986). The cellular homologue of the transforming gene of SKV avian retrovirus maps to human chromosome region 1q22→q24. Cytogenetic and Genome Research. 43(3-4). 181–186. 41 indexed citations

20.

Tantravahi, Umadevi, Vundavalli V. Murty, S.C. Jhanwar, et al.. (1986). Physical mapping of the factor VIII gene proximal to two polymorphic DNA probes in human chromosome band Xq28: implications for factor VIII gene segregation analysis. Cytogenetic and Genome Research. 42(1-2). 75–79. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact